EUVIMEDEUVIMED entdecken
Vergleichsstudie

Head-to-Head Comparison of [ 68 Ga]Ga-NOTA-RM26 and [ 18 F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study

Rongxi Wang, Weiming Kang, Zhen Liu, Yumin Zheng, Huimin Sui, Linlin Li, Jiarou Wang, Jialin Xiang, Xingtong Peng, Xiaoyuan Chen, Zhaohui Zhu, Jingjing Zhang

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.267810 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Rongxi Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and …. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Gastrointestinal Stromal Tumors, Fluorodeoxyglucose F18, Heterocyclic Compounds, 1-Ring. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal stromal tumors (GISTs) are the most common stromal tumors in the gastrointestinal tract. This study was designed to evaluate a gastrin-releasing peptide receptor antagonist PET tracer, [68Ga]Ga-NOTA-RM26, and compare it with [18F]FDG PET/CT in the assessment of patients with GISTs.

Methods

With institutional review board approval and informed consent, 30 patients with suspected or proven GISTs based on abdominal CT or gastroscopy were recruited. All patients underwent [68Ga]Ga-NOTA-RM26 and [18F]FDG PET/CT scans. Pathology and other patient information were collected.

Results

No radiopharmaceutical-related adverse events were observed in the patients. In total, 18 lesions in 16 patients were diagnosed as GIST, 3 patients were diagnosed with schwannoma, and 4 patients were diagnosed with leiomyoma. In 18 GISTs, the mean SUVmax of [68Ga]Ga-NOTA-RM26 PET was significantly higher than that of [18F]FDG PET (17.07 ± 19.57 vs. 2.28 ± 1.65; P < 0.01), and [68Ga]Ga-NOTA-RM26 PET/CT had a higher tumor detection rate than did [18F]FDG PET/CT (88.9% vs. 50%; P < 0.01). The uptake of [68Ga]Ga-NOTA-RM26 in GISTs was significantly higher than that in 2 other benign tumors (leiomyoma or schwannoma) (17.07 ± 19.57 vs. 4.23 ± 1.77; P = 0.014). With the SUVmax cutoff value of 6.0, the sensitivity of 68Ga-NOTA-RM26 PET/CT in diagnosing GISTs is 72% and the specificity is 85.7%.

Conclusion

Compared with [18F]FDG PET/CT, [68Ga]Ga-NOTA-RM26 PET/CT is a promising and effective imaging modality for the detection of GISTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyGastrointestinal Stromal TumorsFluorodeoxyglucose F18Heterocyclic Compounds, 1-RingHeterocyclic CompoundsHumansMaleFemaleMiddle AgedAgedProspective StudiesGallium RadioisotopesAdultAged, 80 and overRadiopharmaceuticals

Stichwörter der Autor:innen

GRPR antagonist[18F]FDG[68Ga]Ga-NOTA-RM26gastrin-releasing peptide receptorgastrointestinal stromal tumor

Substanzen

Fluorodeoxyglucose F18Gallium RadioisotopesHeterocyclic Compounds, 1-RingHeterocyclic Compounds1,4,7-triazacyclononane-N,N',N''-triacetic acidRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Ch…
  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Theranostics Center of Excellence, Yong Loo Lin School of Medicine, National University of Singapore, Helios, Singapore.
  • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of General Surgery, Beijing Friendship Hospital, Capital Medical University and National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Department of Nuclear Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Zitieren

APA

Wang, R., Kang, W., Liu, Z., Zheng, Y., Sui, H., Li, L., Wang, J., Xiang, J., Peng, X., Chen, X., Zhu, Z., & Zhang, J. (2025). Head-to-Head Comparison of [ 68 Ga]Ga-NOTA-RM26 and [ 18 F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267810

Vancouver

Wang R, Kang W, Liu Z, Zheng Y, Sui H, Li L, et al. Head-to-Head Comparison of [ 68 Ga]Ga-NOTA-RM26 and [ 18 F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.267810

BibTeX
@article{Wang2025,
  author = {Wang, Rongxi and Kang, Weiming and Liu, Zhen and Zheng, Yumin and Sui, Huimin and Li, Linlin and Wang, Jiarou and Xiang, Jialin and Peng, Xingtong and Chen, Xiaoyuan and Zhu, Zhaohui and Zhang, Jingjing},
  title = {Head-to-Head Comparison of [ 68 Ga]Ga-NOTA-RM26 and [ 18 F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.267810}
}
Kostenlos starten →